Serum triglycerides and risk of cardiovascular disease
| Autor: | Anton F. H. Stalenhoef, J. de Graaf, A.C.I. Boullart |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Disease Bioinformatics chemistry.chemical_compound Risk Factors Internal medicine Epidemiology medicine Humans Serum triglycerides Risk factor Molecular Biology Health aging / healthy living Cardiovascular diseases [IGMD 5] Triglycerides Hypertriglyceridemia Triglyceride Cholesterol business.industry Cell Biology Lipid Metabolism medicine.disease Endocrinology chemistry Cardiovascular Diseases business Dyslipidemia |
| Zdroj: | Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1821, 867-75 Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1821, 5, pp. 867-75 |
| ISSN: | 1388-1981 |
| Popis: | Item does not contain fulltext Dyslipidemia, especially elevated serum levels of cholesterol, is causally related to cardiovascular disease. The specific role of triglycerides has long been controversial. In this article we discuss the role of serum triglycerides in relation to the risk of cardiovascular disease. First, the (patho)physiology of triglycerides is described, including the definition and a short summary of the primary and secondary causes of hypertriglyceridemia. Furthermore, we will give an overview of the published epidemiological studies concerning hypertriglyceridemia and cardiovascular disease to support the view that triglyceride-rich lipoproteins are an independently associated risk factor. Finally, treatment strategies and treatment targets are discussed. This article is part of a Special Issue entitled Triglyceride Metabolism and Disease. 01 mei 2012 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect